{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:43:17Z","timestamp":1792122197819,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":1096,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jpainsymman.2017.10.017","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T04:16:00Z","timestamp":1509509760000},"page":"998-1003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Methadone as a First-Line Opioid in Cancer Pain Management: A Systematic Review"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9859-6487","authenticated-orcid":false,"given":"Sebastiano","family":"Mercadante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Bruera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2017.10.017_bib1","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","article-title":"Update on prevalence of pain in patients with cancer: systematic review and Meta-analysis","volume":"51","author":"van den Beuken-van Everdingen","year":"2016","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib2","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/S0140-6736(11)60236-5","article-title":"Treatment of cancer pain","volume":"377","author":"Portenoy","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib3","first-page":"CD012592","article-title":"Opioids for cancer pain\u2013an overview of Cochrane reviews","volume":"7","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2015.10.049","article-title":"Opioid metabolism and clinical aspects","volume":"769","author":"Mercadante","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1526-4637.2006.00289.x","article-title":"Actual and potential drug interactions associated with methadone","volume":"9","author":"Weschules","year":"2008","journal-title":"Pain Med"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jpainsymman.2007.11.003","article-title":"Methadone: to ECG or not to ECG. That is still the question","volume":"36","author":"Cruciani","year":"2008","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.critrevonc.2015.12.011","article-title":"Opioid switching in cancer pain: from the beginning to nowadays","volume":"99","author":"Mercadante","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib8","first-page":"2225","article-title":"The poor use of methadone in Italian hospices","volume":"21","author":"Mercadante","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1155\/2013\/740379","article-title":"Continuing methadone for pain in palliative care","volume":"18","author":"Hawley","year":"2013","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib10","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1185\/03007995.2011.635197","article-title":"Outcome of opioid switching 4 weeks after discharge from a palliative care unit","volume":"27","author":"Mercadante","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib11","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1089\/jpm.2012.0612","article-title":"The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia","volume":"16","author":"Salpeter","year":"2013","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1090-3801(97)90064-1","article-title":"Methadone in cancer pain","volume":"1","author":"Mercadante","year":"1997","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(97)13391-2","article-title":"The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord","volume":"223","author":"Gorman","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3959(93)90125-9","article-title":"Methadone in the management of cancer pain: a review","volume":"52","author":"Fainsinger","year":"1993","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/15360288.2014.938883","article-title":"Therapeutic challenges in cancer pain management: a systematic review of methadone","volume":"28","author":"Good","year":"2014","journal-title":"J\u00a0Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/oxfordjournals.annonc.a010679","article-title":"Patient-controlled analgesia with oral methadone in cancer pain: preliminary report","volume":"7","author":"Mercadante","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib17","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ejpain.2008.01.013","article-title":"Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management","volume":"12","author":"Mercadante","year":"2008","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib18","first-page":"957963","article-title":"A\u00a0prospective, open study of oral methadone in the treatment of cancer pain","volume":"16","author":"Bruera","year":"2000"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib19","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1089\/jpm.2017.0090","article-title":"Clinical outcomes of start-low, Go-slow methadone initiation for cancer-related pain: What's the Hurry?","volume":"20","author":"Hawley","year":"2017","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1089\/jpm.2014.0266","article-title":"The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report","volume":"18","author":"Salpeter","year":"2015","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib21","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/bmj.282.6266.771","article-title":"Patient-controlled dose regimen of methadone for chronic cancer pain","volume":"282","author":"Sawe","year":"1981","journal-title":"Br Med J"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib22","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1200\/JCO.1996.14.10.2836","article-title":"Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients","volume":"14","author":"De Conno","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0885-3924(99)00048-2","article-title":"Methadone response in advanced cancer patients with pain followed at home","volume":"18","author":"Mercadante","year":"1999","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/cncr.24754","article-title":"Methadone initiation and rotation in the outpatient setting for patients with cancer pain","volume":"116","author":"Parsons","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib25","first-page":"3351","article-title":"Methadone as first-line opioid treatment for cancer pain in a developing country palliative care unit","volume":"24","author":"Peraino","year":"2016","journal-title":"Support Care cancer"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0885-3924(86)80042-2","article-title":"A\u00a0randomized study on oral administration of morphine and methadone in the treatment of cancer pain","volume":"1","author":"Ventafridda Ventafridda","year":"1986","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib27","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1200\/JCO.1998.16.11.3656","article-title":"Morphine versus methadone in the pain treatment of advanced cancer patients followed up at home","volume":"16","author":"Mercadante","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1200\/JCO.2004.03.172","article-title":"Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study","volume":"22","author":"Bruera","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejca.2016.06.025","article-title":"Methadone is superior to fentanyl in treating neuropathic pain in patients with head-and-neck cancer","volume":"65","author":"Haumann","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpainsymman.2017.10.017_bib30","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based 14. Recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncol"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392417305973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392417305973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:23:11Z","timestamp":1760131391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392417305973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0885392417305973"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2017.10.017","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methadone as a First-Line Opioid in Cancer Pain Management: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2017.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}